Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Infection|April 23, 2026
Host response profiling reveals heterogenous immune responses in hospitalised adults with respiratory viral detectionAlex R Tanner, Bilge Eylem Dedeoglu, Nathan J Brendish, et al.
The Journal of Infection|November 17, 2023
Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulationNathan J Brendish, Cai Davis, Mary E Chapman, et al.
The Journal of Infection|September 7, 2024
Real-world performance of a single-use, analyser-free, molecular point-of-care test for COVID-19 used in the emergency department: Results of a prospective trial (ED-POC)Mary E Chapman, Nathan J Brendish, Matthew Morris, et al.
The Journal of Infection|June 25, 2020
Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19Tristan W Clark, Nathan J Brendish, Stephen Poole, et al.
The Journal of Infection|February 2, 2022
Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19Robert Livingstone, Hlaing Lin, Nathan J Brendish, et al.
The Lancet. Respiratory Medicine|April 11, 2017
Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trialNathan J Brendish, Ahalya K Malachira, Lawrence Armstrong, et al.
The Lancet. Respiratory Medicine|December 7, 2020
Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trialTristan W Clark, Kate R Beard, Nathan J Brendish, et al.
Infectious Diseases and Therapy|May 9, 2022
Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy StudyNathan J Brendish, Alex R Tanner, Stephen Poole, et al.
The Lancet. Infectious Diseases|April 28, 2023
Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trialNathan J Brendish, Kate R Beard, Ahalya K Malachira, et al.
The Journal of Infection|September 30, 2020
Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infectionNathan J Brendish, Stephen Poole, Vasanth V Naidu, et al.
Pageof 3